BIRC5 and hepatocellular carcinoma: The ability of YM155 to inhibit the anchorage-independent cell growth, to induce cell cycle arrest, apoptosis and DNA damage of high survivin-expressing sensitive HCC cells suggests the therapeutic potential of YM155 on this molecular subtype of HCC cells.